SMOFKABIVEN LOW OSMO amino acids 2.5%, electrolytes 0.4%, lipids 3.5% & glucose 6.8% emulsion for intravenous infusion 2500 mL biofine bag Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

smofkabiven low osmo amino acids 2.5%, electrolytes 0.4%, lipids 3.5% & glucose 6.8% emulsion for intravenous infusion 2500 ml biofine bag

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium oleate; sodium hydroxide; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN LOW OSMO amino acids 2.5%, electrolytes 0.4%, lipids 3.5% & glucose 6.8% emulsion for intravenous infusion1950 mL biofine bag Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

smofkabiven low osmo amino acids 2.5%, electrolytes 0.4%, lipids 3.5% & glucose 6.8% emulsion for intravenous infusion1950 ml biofine bag

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium oleate; sodium hydroxide; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN LOW OSMO amino acids 2.5%, electrolytes 0.4%, lipids 3.5% & glucose 6.8% emulsion for intravenous infusion 1400 mL biofine bag Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

smofkabiven low osmo amino acids 2.5%, electrolytes 0.4%, lipids 3.5% & glucose 6.8% emulsion for intravenous infusion 1400 ml biofine bag

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium oleate; sodium hydroxide; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN LOW OSMO amino acids 2.5%, electrolytes 0.4%, lipids 3.5% & glucose 6.8% emulsion for intravenous infusion 850 mL biofine bag Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

smofkabiven low osmo amino acids 2.5%, electrolytes 0.4%, lipids 3.5% & glucose 6.8% emulsion for intravenous infusion 850 ml biofine bag

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium oleate; sodium hydroxide; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

KABIVEN G 11% 2400mL injection bag Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

kabiven g 11% 2400ml injection bag

fresenius kabi australia pty ltd - soya oil, quantity: 200 mg/ml - injection, emulsion - excipient ingredients: water for injections; egg lecithin; sodium hydroxide; glycerol - parenteral nutrition for patients when oral or enteral nutrition is impossible or insufficient or contraindicated.

KABIVEN G 11% 1920mL injection bag Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

kabiven g 11% 1920ml injection bag

fresenius kabi australia pty ltd - soya oil, quantity: 200 mg/ml - injection, emulsion - excipient ingredients: sodium hydroxide; egg lecithin; glycerol; water for injections - parenteral nutrition for patients when oral or enteral nutrition is impossible or insufficient or contraindicated.

StructoKabiven Singapoo - Kiingereza - HSA (Health Sciences Authority)

structokabiven

fresenius kabi (singapore) pte ltd - (amino acid solution) calcium chloride dihydrate corresp. to calcium chloride 0.56g; (amino acid solution) glycine (aminoacetic acid); (amino acid solution) l- histidine; (amino acid solution) l- isoleucine; (amino acid solution) l- leucine; (amino acid solution) l- methionine; (amino acid solution) l- serine; (amino acid solution) l- threonine; (amino acid solution) l- valine; (amino acid solution) l-alanine; (amino acid solution) l-arginine; (amino acid solution) l-lysine acetate corresp. to l-lysine 6.6g - emulsion - 0.740g per 1000ml - (amino acid solution) calcium chloride dihydrate corresp. to calcium chloride 0.56g 0.740g per 1000ml; (amino acid solution) glycine (aminoacetic acid) 11.0g per 1000ml; (amino acid solution) l- histidine 3.0g per 1000ml; (amino acid solution) l- isoleucine 5.0g per 1000ml; (amino acid solution) l- leucine 7.4g per 1000ml; (amino acid solution) l- methionine 4.3g per 1000ml; (amino acid solution) l- serine 6.5g per 1000ml; (amino acid solution) l- threonine 4.4g per 1000ml; (amino acid solution) l- valine 6.2g per 1000ml; (amino acid solution) l-alanine 14.0g per 1000ml; (amino acid solution) l-arginine 12.0g per 1000ml; (amino acid solution) l-lysine acetate corresp. to l-lysine 6.6g 9.3g per 1000ml; (amino acid solution) l-phenylalanine 5.1g per 1000ml; (amino acid solution) l-proline 11.2g per 1000ml; (amino acid solution) l-tryptophan 2.0g per 1000ml; (amino acid solution) l-tyrosine 0.40g per 1000ml; (amino acid solution) magnesium sulphate heptahydrate corresp. to magnesium sulphate 1.2g 2.47g per 1000m

POTASSIUM ACETATE injection solution Marekani - Kiingereza - NLM (National Library of Medicine)

potassium acetate injection solution

american regent, inc. - potassium acetate (unii: m911911u02) (potassium cation - unii:295o53k152) - potassium acetate 196 mg in 1 ml

HYDROCORTISONE AND ACETIC ACID solution Marekani - Kiingereza - NLM (National Library of Medicine)

hydrocortisone and acetic acid solution

akorn operating company llc - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - acetic acid 20.75 mg in 1 ml - for the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation. hypersensitivity to hydrocortisone and acetic acid or any of the ingredients; herpes simplex, vaccinia and varicella. perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

SODUM ACETATE- sodium acetate injection, solution, concentrate Marekani - Kiingereza - NLM (National Library of Medicine)

sodum acetate- sodium acetate injection, solution, concentrate

american regent, inc. - sodium acetate anhydrous (unii: nvg71zz7p0) (acetate ion - unii:569dqm74sc, sodium cation - unii:lyr4m0nh37) - sodium acetate anhydrous 328 mg in 1 ml - sodium acetate for injection, usp concentrate is indicated as a source of sodium in patients with restricted or no oral intake. it is also useful as an additive for preparing specific intravenous fluid formulas, when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. sodium acetate for injection, usp concentrate is contraindicated in patients with hypernatremia.